Diabetes drug metformin may boost heart ablation success
NCT ID NCT04625946
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study looked at whether metformin, a common diabetes medication, can reduce the return of irregular heartbeats in people with atrial fibrillation who undergo a heart procedure called ablation. 117 participants were randomly assigned to receive metformin or no additional treatment, and all received standard lifestyle advice. The goal was to see if metformin helps keep the heart in normal rhythm for up to a year after the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.